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Striated preferentially expressed gene (Speg) is a member of the myosin light chain kinase
family. We previously showed that disruption of the Speg gene locus in mice leads to a dilated
cardiomyopathy with immature-appearing cardiomyocytes. Here we show that cardiomyo-
pathy of Speg / mice arises as a consequence of defects in cardiac progenitor cell (CPC)
function, and that neonatal cardiac dysfunction can be rescued by in utero injections of
wild-type CPCs into Speg / foetal hearts. CPCs harvested from Speg / mice display
defects in clone formation, growth and differentiation into cardiomyocytes in vitro, which are
associated with cardiac dysfunction in vivo. In utero administration of wild-type CPCs into the
hearts of Speg / mice results in CPC engraftment, differentiation and myocardial
maturation, which rescues Speg / mice from neonatal heart failure and increases the
number of live births by ﬁvefold. We propose that in utero administration of CPCs may have
future implications for treatment of neonatal heart diseases.
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C
ongenital heart disease is the most common congenital
disorder in newborns, and the most frequent cause of
infant death from birth defects1. In addition to these
structural defects of the heart, cardiomyopathies are also a
signiﬁcant cause of heart failure in children2. The sarcomere is
the functional unit of striated muscle that generates contraction,
and mutations in sarcomeric proteins may lead to either
dilated or hypertrophic cardiomyopathies3–7. More speciﬁcally,
mutations of proteins localized to the Z-disc, which deﬁnes the
lateral border of the sarcomere, are involved in a variety of
human cardiomyopathies5. We have previously shown that
mutation of the striated preferentially expressed gene (Speg) in
mice, which co-localizes with desmin at the Z-disc and is part of a
muscle-speciﬁc gene locus8,9, leads to a dilated cardiomyopathy
in mice10. Interestingly, mutations in the gene encoding Speg have
recently been found in patients with centronucelar myopathy,
a congenital skeletal muscle condition, and these patients
additionally present with a dilated cardiomyopathy11.
The Speg gene locus, through alternative promoter use and
splicing in a tissue-speciﬁc manner, generates four different
isoforms8. Spega and Spegb are expressed speciﬁcally in striated
muscle, and these two isoforms along with obscurin are unique
members of the myosin light chain kinase (MLCK) family,
containing two tandemly arranged serine/threonine kinase
(MLCK) domains12. We have previously shown that during
development, Speg isoforms are expressed predominantly in the
heart throughout the ﬁrst 18.5 days-post coitum (dpc)10. At that
point in time, Speg mutant hearts have already begun to enlarge
and exhibited marked cardiac dysfunction. Furthermore, we
demonstrated that in Speg mutant hearts, there was evidence for
decreased phosphorylation of a-tropomyosin10, a protein that
resides in the thin ﬁlament of the sarcomere, and anchors at the
Z-disc. Mutations in a-tropomyosin have also been found in
patients with familial dilated cardiomyopathy13–15. It is known
that the Z-disc is functionally important for more than just
structural stability and force transmission, but also for cell
signalling5. Our data suggest that like other sarcomeric Z-disc
proteins, mutation of Speg may lead to more than just a structural
abnormality of the sarcomere, and potentially has additional
consequences leading to abnormal function of cardiomyocytes.
When assessing the structural organization of the Speg mutant
(Speg / ) hearts at 18.5 dpc, we found a reduced density of
myocyte nuclei per unit area of tissue, in the absence of increased
myocyte death10. Also, Speg / hearts were composed of
myocytes that were 20% larger than wild-type (Spegþ /þ )
myocytes. These data suggested that mutation of the Speg gene
locus altered the generation of cardiac parenchymal cells,
particularly cardiomyocytes, during development. Electron
microscopy of Speg mutant hearts at 18.5 dpc revealed evidence
of myoﬁbril disarray10. While this may be seen in failing hearts16,
the thin, loosely arranged and less organized myoﬁbrils of the
Speg mutant hearts also depict a less mature myocyte17–19
compared with wild-type hearts. Of note, we previously
demonstrated an increased expression of Spega during
differentiation of C2C12 myoblasts into myotubes8. While we
proposed at the time that Spega might serve as a sensitive marker
of striated muscle differentiation, it is also feasible that expression
of Speg isoforms may be important for cellular commitment and
maturation.
Since the Speg mutant hearts have an abnormality in the
generation of cardiomyocytes10, and expression of Speg isoforms
have been associated with differentiation of striated muscle cells8,
we speculated that Speg may be important for cardiac progenitor
cell (CPC) function. It has been suggested previously that the
formation of cardiomyocytes from the differentiation of CPCs is
critical for cardiac growth during development20. While a recent
mouse lineage tracing study challenged the importance of c-kit-
positive CPCs in the regulation of cardiomyocyte renewal21,
further investigations need to be performed22. Nevertheless, the
multipotency and regenerative capabilities of harvested c-kit-
positive CPCs have been extensively studied and conﬁrmed by
numerous laboratories23. In fact, the lineage tracing mice
conﬁrmed the presence of endogenous c-kit-positive cells that
produce cardiomyocytes in the mouse heart21. A predominant
fraction of CPCs in embryonic, foetal and neonatal hearts are
positive for c-kit, and have the properties of clonogenicity, self-
renewal and multipotency20,24–26. Thus, in the present study we
wanted to determine whether c-kit-positive CPCs harvested from
Speg mutant mice have functional abnormalities, and to
determine whether administration of wild-type CPCs in utero
could rescue the cardiac phenotype of Speg mutant mice.
Speg / CPCs revealed defects in clone formation, growth and
differentiation into cardiomyocytes in vitro, and were associated
with cardiac dysfunction in vivo. Administration of wild-type
CPCs into the hearts of Speg / foetuses resulted in CPC
engraftment, differentiation and myocardial maturation, which
rescued Speg / mice from neonatal heart failure. These data
suggest that in utero administration of CPCs may have future
implications for treatment of neonatal heart diseases.
Results
Immature myocytes in the hearts of Speg mutant mice. Hearts
harvested from Spegþ /þ and Speg / mice on postnatal day 1
were sectioned and stained for cardiac troponin T (cTnT), and
confocal imaging was performed. In comparison with the mature
appearing, striated cardiomyocytes of the Spegþ /þ hearts
(Fig. 1a, left panel), cardiomyocytes from Speg / hearts
revealed a lack of striations and a less organized appearance
(Fig. 1a, right panel). To further assess ultrastructural changes, we
harvested Speg mutant and wild-type hearts at 18.5 dpc and
performed transmission electron microscopy. Figure 1b (left
panel) demonstrated mature appearing myocytes in hearts of
Spegþ /þ mice. The myoﬁbrils (arrows) were thick with well
deﬁned sarcomeres, and the myoﬁbrils occupied a large portion
of the cellular cytoplasm. In contrast, the myoﬁbrils in Speg /
hearts were much thinner and loosely arranged (Fig. 1b, right
panel, arrows), and the cytoplasm appears much less dense.
Quantitation of the composition of cardiomyocytes by electron
microscopy in the two groups revealed a marked reduction in the
volume fraction of myoﬁbrils, and an increased volume fraction
of undifferentiated cytoplasm, in Speg / compared with
Spegþ /þ cardiomyocytes (Fig. 1c). There was no signiﬁcant
alteration in the volume composition of mitochondria or nuclei in
cardiomyocytes between the two groups. These data are con-
sistent with immature myocytes in the Speg / hearts, and led
us to investigate CPCs in Speg mutant compared with wild-type
hearts.
Characterization of mouse CPCs. Hearts were harvested from
either Spegþ /þ or Speg / mice on day 1 after birth, the tissue
was digested, single-cell suspensions generated and c-kit-positive
cells were isolated using ﬂuorescence-activated cell sorting
(FACS) or magnetic bead immunoselection. Initial evaluation of
Spegþ /þ cells after expansion in culture showed that 93% of cells
were positive for c-kit after FACS or bead isolation (Fig. 2a, left
panel). Conﬁrmation of c-kit-positive cells is shown by confocal
imaging with immunostaining for c-kit (Fig. 2a, middle panel),
and ﬂuorescent microscopy for immunostaining of c-kit in an
entire clone (Fig. 2a, right panel, and a second clone in
Supplementary Fig. 1) that originated from a single cell. The
c-kit-positive cells harvested from Spegþ /þ hearts showed
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expression of Speg by quantitative real-time PCR (qRT-PCR), but
no expression was found in cells harvested from Speg / hearts
(Supplementary Fig. 2).
Cells positive for c-kit expanded in culture demonstrated a low
expression of the haematopoietic marker CD34, and these cells
were negative for CD133 and for markers of bone marrow-
derived immune cells such as CD45, CD11b and CD11c
(Supplementary Fig. 3a). We recently showed that c-kit-positive
cells of embryonic, foetal and neonatal hearts are from cardiac
mesoderm, and not of bone marrow origin27. A high percentage
of c-kit-isolated cells expressed Sca1, and a subpopulation of cells
showed evidence for markers CD105, CD73 and CD90.2
(Supplementary Fig. 3b). To conﬁrm we were not isolating
mesenchymal stromal cells (MSCs) from the hearts, we took
CPCs and MSCs28 (positive control) and placed them in
adipogenic differentiation medium in culture. As expected, the
MSCs differentiated into adipocytes (left panel, red stain for Oil
Red O), however Spegþ /þ (middle panel) and Speg / (right
panel) CPCs showed no evidence of adipocyte differentiation
(Supplementary Fig. 4). These data conﬁrm that our cells-of-
interest were not MSCs harvested from newborn hearts. In
addition, the relationship between c-kit-positive CPCs and the
MSC hierarchy of cells remains unknown.
The c-kit-isolated cells from both Spegþ /þ and Speg /
hearts were predominantly negative for a marker of commitment
(GATA4) and also for transcription factors and cytoplasmic
proteins characteristic of cardiomyocytes (Nkx2.5 and sarcomeric
a-actin, respectively), smooth muscle cells (GATA6 and
calponin) and endothelial cells (Ets 1, CD31 and Flk-1)
(Supplementary Fig. 3c). These data support the fact that the
c-kit-isolated cells were undifferentiated, and there was no
apparent difference between Spegþ /þ and Speg / cells. When
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Figure 1 | Structure of Speg / hearts. (a) Confocal imaging of cardiac troponin T (cTnT) staining (red) of myocytes from the left ventricle of
Spegþ /þ (left panel) and Speg / (right panel) hearts at postnatal day 1. The heart tissue was co-stained with 40,6-diamidino-2-phenylindole (DAPI,
blue) to identify nuclei. The scale bar, 10mm. (b) Electron microscopy imaging of myocardium from Spegþ /þ (left panel) and Speg / (right panel)
hearts at 18.5 dpc. Arrows point to myoﬁbrils. N, nucleus; M, mitochondria. The scale bar, 1 mm. (c) Volume fraction of myoﬁbrils, mitochondria, nuclei
and undifferentiated cytoplasm in cardiomyocytes of Spegþ /þ (white bars) and Speg / (black bars) hearts (n¼4 per group) was performed on
electron microscopy images. Data are presented as mean±s.e.m. * versus Spegþ /þ . P¼0.007 for myoﬁbrils and P¼0.004 for undifferentiated
cytoplasm, using Student’s unpaired t-test. NS, not signiﬁcant.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms9825 ARTICLE
NATURE COMMUNICATIONS | 6:8825 | DOI: 10.1038/ncomms9825 |www.nature.com/naturecommunications 3
& 2015 Macmillan Publishers Limited. All rights reserved.
Spegþ /þ cells were placed in specialized differentiation media
for different cell types in culture, qRT-PCR revealed increased
expression of transcription factors for commitment into
cardiomyocyte (Nkx2.5 and MEF-2C), smooth muscle cell
(GATA6) and endothelial (VEZF1) lineages compared with
non-differentiated cells (Fig. 2b). In these same differentiation
conditions, staining for immuocytochemistry demonstrated
that c-kit-isolated cells from Spegþ /þ hearts differentiated into
cardiomyocytes, by staining for cTnT (Fig. 2c, left panel); smooth
muscle cells, by staining for calponin (Fig. 2c, middle panel); and
endothelial cells, by staining for von Willebrand factor (vWF,
Fig. 2c, right panel). When the CPCs were cultured in medium
containing dexamethasone, a nonselective stimulus for CPC
differentiation (but not a potent stimulus for any speciﬁc lineage),
ﬂow cytometry demonstrated that the c-kit-isolated cells
from Spegþ /þ hearts also differentiated into cardiomyocytes
1020 103 104 102 103 104105 105 102 103 104 105
APC-A
0
20
40
60
80
100
28
%
 o
f m
ax
12
0
APC-A
0
20
40
60
80
100
%
 o
f m
ax
8
0
APC-A
0
20
40
60
80
100
%
 o
f m
ax
cTnT Calponin vWF
Nkx2.52.5
0
0.5
1.0
1.5
2.0
Undiff Diff
3.5
3.0
2.5
2.0
1.5
1.0
0.5
0
MEF2C
Undiff Diff
TF
/G
AP
DH
 m
RN
A
(fo
ld 
inc
rea
se
)
* *
6
0
1
2
3
4
5
DiffUndiff
GATA6 * 8
0
1
2
3
4
5
6
7
Undiff Diff
VEZF1 *
Calponin
c-kit c-kit 
0 102 103 104 105
PE-Cy7-A
0
20
40
60
80
100
93
%
 o
f m
ax
c-kit 
cTnT vWF
- it
Figure 2 | Characterization of CPCs. (a) Representative ﬂow cytometric analyses assessing the percentage of c-kit-positive cells (93%) after isolation
using c-kit-beads (left panel). The middle panel demonstrates confocal imaging of putative CPCs stained for c-kit (green) and DAPI (blue). The scale bar,
20mm. In the right panel, a putative CPC clone is stained for c-kit (green) and DAPI (blue). The scale bar, 1,000mm. (b) Total RNA was isolated from
putative CPCs cultured in growth (Undiff) or cell-speciﬁc differentiation (Diff) medium (see methods), and quantitative real-time PCR was performed for
transcription factors (TF) Nkx2.5 (n¼ 5) and MEF-2C (n¼4) for cardiomyocytes, GATA6 (n¼4–5) for smooth muscle cells and VEZF1 (n¼4) for
endothelial cells. Data are presented as mean±s.e.m. * versus undifferentiated cells, P¼0.026 for Nkx2.5, P¼0.0016 for MEF-2C, P¼0.012 for GATA6
and P¼0.026 for VEZF1 using Student’s unpaired t-test. (c) Putative CPCs were cultured in cell-speciﬁc differentiation medium (see methods) and
confocal imaging of cells was performed after staining for cardiac troponin T (cTnT, red, left panel), smooth muscle calponin (red, middle panel) and von
Willebrand factor (vWF, red, right panel). The scale bar, 20mm. (d) Putative CPCs were cultured in medium containing 10 nM dexamethasone for unbiased
differentiation, and assessed by ﬂow cytometry for the percentage of cells positive for cTnT (28%, left panel), calponin (12%, middle panel) and vWF
(8%, right panel). The black line represents the target antibody, and the grey line represents the isotype control antibody.
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(cTnT, Fig. 2d, left panel), smooth muscle cells (calponin, Fig. 2d,
middle panel) and endothelial cells (vWF, Fig. 2d, right panel).
These data reveal that Spegþ /þ CPC are capable of differentiat-
ing into three different cell types; and when placed in a
nonselective differentiation medium, the CPCs have a tendency
to differentiate into cardiomyocytes (28%) more than smooth
muscle cells (12%) or endothelial cells (8%) (Fig. 2d).
Furthermore, the expression level of Speg mRNA increased
threefold in wild-type CPCs placed in cardiomyocyte differentia-
tion conditions in culture (Supplementary Fig. 2).
Properties of CPCs harvested from Spegþ /þ and Speg /
mice. Initially we investigated whether there was a disparity in the
number of c-kit-positive, lineage-negative cells in Speg mutant
compared with wild-type hearts at day 1 after birth. As shown in
Fig. 3a, there was no difference in the percentage of c-kit-positive,
lineage-negative cells (expressed as a percentage of total cells)
harvested from Spegþ /þ (0.39±0.05) and Speg / (0.41±0.07)
hearts. We next assessed whether a decrease in the expression of
Speg would have an effect on CPC function in vitro, by investi-
gating progenitor cell properties (clone formation, self-renewal
and multipotency) of c-kit-isolated CPCs in each group. These
studies were performed using limited dilution assays, as Speg /
cells did not survive after FACS when seeded in Terasaki plates.
Clones formed from Speg mutant CPCs were much smaller than
clones from wild-type CPCs, even when cultured for longer
periods of time (Fig. 3b). Moreover, quantitation of the number
of cells per clone was signiﬁcantly less in Speg / CPCs
(286±137) at day 40 compared with Spegþ /þ CPCs
(1,176±254) at day 20 (Fig. 3c). Clonal efﬁciency was assessed,
and the percentage of clones formed from Speg / CPCs was
dramatically decreased compared with clonal efﬁciency of wild-
type CPCs (Fig. 3d). In fact, very few clones were detected from
Speg mutant CPCs until 40 days after plating (0.27±0.03%)
compared with wild-type CPCs (6.84±0.47%). Proliferation of
Speg mutant and wild-type CPCs were next assessed in vitro. An
identical number of cells were plated, and then counted daily over
a 5-day period. Proliferation of Speg / CPCs (black squares)
was signiﬁcantly less than Spegþ /þ cells (white circles) by days 4
and 5 (Fig. 3e). We analysed the logarithmic growth of the cells,
and the rate was 2.6±0.5-fold greater for the Spegþ /þ compared
with the Speg / cells. This difference in growth of cultured cells
was also conﬁrmed by bromodeoxyuridine (BrdU) labelling on
day 5 (Fig. 3f), with the rate of growth 1.9±0.6 fold greater
for Spegþ /þ compared with the Speg / cells. These data
demonstrate the growth potential was signiﬁcantly reduced in
Speg mutant versus wild-type CPCs.
In the ﬁnal assessment of progenitor cell properties, we
assessed the differentiation of Spegþ /þ and Speg / CPCs into
cardiomyocytes in vitro. The majority of wild-type CPCs
(83.8±6.2%) were able to differentiate into cardiomyocytes using
specialized differentiation medium in culture, as conﬁrmed by
immunocytochemical staining for sarcomeric a-actin (Fig. 4a,
left panel). In contrast, markedly fewer CPCs from Speg
mutant hearts (11.9±3.8%) were able to differentiate into
cardiomyocytes (Fig. 4a, right panel). Figure 4b shows the
quantitative analysis of the immunostaining for sarcomeric
a-actin in Spegþ /þ and Speg / CPCs, in the presence or
absence of differentiation medium. This defect in differentiation
of Speg mutant CPCs was also conﬁrmed at the level of mRNA by
performing qRT-PCR for cTnT in the cells, in the presence or
absence of differentiation medium (Fig. 4c). In both of these
analyses, the expression levels for markers of cardiomyocytes
were markedly lower in Speg / CPCs compared with Spegþ /þ
CPCs exposed to differentiation medium. Taken together, our
data demonstrate that CPCs harvested from Speg mutant hearts
have a decreased ability to form clones, to proliferate and to
differentiate into cardiomyocytes compared with wild-type CPCs.
Rescue of Speg / mice by in utero injection of Spegþ /þ
CPCs. Under echocardiographic guidance, using a beveled glass
micropipette, we initially injected CPCs—expanded in culture
and then ﬂuorescently labelled green (PKH67)—into hearts of
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Figure 3 | Clone formation and growth curves of CPCs. (a) Percentage of
c-kit-positive (þ ) Lineage-negative ( ) cells from hearts of Spegþ /þ
(white circles, n¼ 11) and Speg / (black squares, n¼ 8) mice by ﬂow
cytometry. Hearts from day 1 pups were harvested and total cells were
collected following enzyme digestion. NS, not signiﬁcant using Student’s
unpaired t-test. (b) CPCs were plated in limited dilution, and monitored
in growth medium. Phase contrast images of representative clones of
Spegþ /þ CPCs after 10 days in culture (D10þ /þ , left panel) and
Speg / CPCs after 20 days in culture (D20 / , right panel). The scale
bar, 250mm. (c) Quantitation of cells per clone after 20 days in culture for
Spegþ /þ clones (white circles, n¼ 29), and after 40 days in culture for
Speg / clones (black squares, n¼ 5). *Po0.01 versus Spegþ /þ clones
using Mann–Whitney U-test. (d) Spegþ /þ (white bars) and Speg /
(black bars) CPCs were assessed for efﬁciency of clone formation after
limited dilution plating, and depicted as a percentage of total cells forming
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Newman–Keuls multiple comparison test. These experiments were
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*P¼0.007 at day 4, and P¼0.0032 at day 5 versus Spegþ /þ cells
using two-way analysis of variance. (f) Spegþ /þ (white bar, n¼ 10) and
Speg / (black bar, n¼ 6) CPCs were plated and grown under growth
conditions, labelled with BrdU and the percentage of nuclei incorporating
BrdU was assessed at day 5. *P¼0.031 versus Spegþ /þ cells using
Student’s unpaired t-test. For a,c–f data are presented as mean±s.e.m.
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wild-type mouse foetuses at 13.5 dpc (Fig. 5a, example of
injection into the septum). Figure 5b shows the location of
injected cells (septum example) by co-injecting with rhodamine-
labelled beads. For the rescue experiments, injections were given
into the walls of the left ventricle (LV), septum and right ventricle
(RV) (see Methods for details). After injection, the pups were
allowed to be born naturally 6 days later, and the hearts were
harvested on day 1 after birth (19.5 dpc). In a subgroup of mice,
the hearts were digested, the cells dissociated and ﬂow cytometry
performed. Figure 5c displays a pseudo-colour density plot, with
evidence for exogenously administered CPCs in day 1 hearts
(demarcated in the rectangular gated area). The confocal images
show green ﬂuorescence for the exogenously injected CPCs
(Fig. 5d), and red staining for sarcomeric a-actin, highlighting
cardiomyocytes (Fig. 5e). In the merged image (Fig. 5f), there is
evidence for engrafted CPCs that subsequently differentiated into
cardiomyocytes (yellow), and also CPCs that remained in an
undifferentiated state (green). Figure 5f (inset) shows a higher
power view of a merged image. The CPCs that have differentiated
into cardiomyocytes (yellow) have an appearance very similar
to endogenous myocytes (red). In addition, c-kit-positive CPCs
harvested from transgenic mice expressing enhanced green
ﬂuorescent protein (GFP) under the direction of the human
ubiqutin C promoter showed this same mature appearance
(Supplementary Fig. 5). To further assess undifferentiated CPCs
in the myocardium, confocal microscopy was performed. We
found a cluster of exogenous CPCs (green, Fig. 5g), which also
stained positive for c-kit (red, Fig. 5h). The merged image (Fig. 5i)
reveals a cluster of undifferentiated, exogenous CPCs (yellow),
forming a putative niche in the myocardium. Taken together,
these data demonstrate that not only do CPCs injected in utero
differentiate into mature appearing cardiomyoctyes postnatally,
but a subpopulation of CPCs remains in an undifferentiated state
and form putative niches. Thus, we next targeted injection of
foetuses from Spegþ / breeding.
Figure 6a shows lower power views of Spegþ /þ and Speg /
hearts (day 1 after birth) that received injections of CPCs (þ )
after expansion in culture, or no CPCs ( ), at 13.5 dpc. The Speg
mutant hearts that received no CPCs appear larger than wild-type
hearts, with no evidence for thickening of the right or left
ventricular walls (Fig. 6a, right upper panel compared with left
upper panel). While administration of CPCs had no apparent
effect on Spegþ /þ hearts (left lower panel), the Speg / hearts
receiving CPCs (right lower panel) appeared smaller than
Speg / hearts receiving no CPCs. We also assessed the hearts
at the level of cardiomyocyte size (Fig. 6b). Overall cardiomyocyte
cross-sectional area was larger in Speg / compared with
Spegþ /þ hearts, consistent with hypertrophic cells, and this
was demonstrated most prominently in myocytes sampled from
the septum. However, after injection of wild-type CPCs into
Speg / hearts, the myocytes from the LV, septum and RV all
demonstrated a reduction in cross-sectional area comparable to
the size of cardiomyocytes from Spegþ /þ hearts (Fig. 6b).
Additional staining for sarcomeric a-actin (red) was performed
on Spegþ /þ and Speg / hearts on day 1 after birth (Fig. 6c).
These mice received intra-cardiac injections of green ﬂuorescently
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labelled CPCs on 13.5 dpc. Engrafted CPCs that differentiated
into cardiomyocytes are demonstrated by yellow staining (Fig. 6c,
merged images). Engraftment and differentiation of CPCs
appeared throughout the RV wall and more localized in the
subendocardial regions of the LV and septum in the Speg /
heart, compared with a diffuse appearance in the Spegþ /þ heart.
However, analysis of entire hearts from all Speg genotypes
revealed no differences in the magnitude of CPC engraftment and
differentiation (see Supplementary Fig. 7). Please note there is a
blood clot in the chamber of the LV of the Speg / heart in
Fig. 6c.
To further assess the expression of Speg, in the presence or
absence of in utero injections of cultured CPCs, we performed
immunostaining for Speg in day 1 postnatal hearts. Fluorescent
microscopy images revealed Speg staining of cardiomyocytes in
wild-type (þ /þ ) hearts not receiving CPCs ( ) (Fig. 7a, left
panel), but no evidence of immunostaining for Speg in mutant
hearts ( / ) not receiving CPCs (Fig. 7a, right panel).
However, after injection of þ /þCPCs into Speg / hearts at
13.5 dpc, the hearts of day 1 neonates revealed regions of
immunostaining for Speg (Fig. 7b, left panel), which was not
present in Speg / hearts receiving  /CPCs (Fig. 7b, right
panel).
The appearance of cardiomyocytes in the ventricular wall
showed that analogous to Fig. 1a, Spegþ /þ hearts have
well-organized cardiomyocytes (Fig. 8a, left panel), while
Speg / hearts have a disorganized appearance by ﬂuorescence
microscopy (Fig. 8a, right panel). However, injection of cultured
wild-type CPCs into Speg / hearts revealed a much more
organized appearance of the mutant myocardium at the cellular
level, with evidence of well-organized myoﬁbres (Fig. 8b, left
panel). Interestingly, Speg / hearts injected with cultured Speg
mutant CPCs (Fig. 8b, right panel) showed some improvement
compared with Speg / hearts not receiving CPCs, however, the
structural appearance of these hearts was more disorganized, with
inconsistent myoﬁbre alignment by cTnT immunostaining
compared with Speg / hearts receiving wild-type CPCs
(Fig. 8b, left panel).
To determine whether the engrafted wild-type CPCs in the
Speg / hearts differentiated into mature cardiomyocytes,
Speg / hearts were co-immunostained for both Speg
and cTnT. As seen by confocal microscopy in Fig. 9a, the
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Figure 5 | Engraftment of cells in recipient hearts after in utero injection of CPCs. (a) CPCs were injected into the myocardium of a wild-type mouse with
a beveled glass micropipette, under echocardiographic guidance, at 13.5 dpc. (b) The CPCs were co-injected with rhodamine-conjugated beads (red),
to demonstrate the instillation of cells. (c) On day 1 after birth (19.5 dpc), hearts injected with CPCs (labelled with PKH67, green) were digested, the cells
dissociated and ﬂow cytometry was performed to identify the presence of exogenously administered cells (FITC for PKH67 in the pseudo-colour density
plot). The positive cells are demarcated in the rectangular gated area. (d–f) Representative images of heart sections day 1 after birth, showing
immunoﬂuorescence for PKH67-labelled exogenous cells (d, green), sarcomeric (Sar) a-actin-positive cardiomyocytes (e, red), and merged images
showing double positive cells (f, yellow). The sections were also counter stained with DAPI (blue). The scale bars, 20mm (d–f); 10mm (f inset).
Double positive cells (from the region outlined by the small rectangle) are shown in a higher magniﬁcation inset of the larger rectangle (f, yellow).
(g–i) Representative images of heart sections day 1 after birth, showing a cluster of exogenous cells with immunoﬂuorescence for PKH67 (g, green with
arrows), c-kit-positive (h, red) and merged images showing double positive cells (i, yellow). The two ﬂuorescent cells with an absence of nuclei (no DAPI
staining, g–i) are red blood cells. The scale bar, 10mm (g–i).
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Speg-expressing cells (green, left panel) in the mutant heart also
expressed cTnT (red, middle panel), with colocalization between
Speg and cTnT (yellow, right panel). Thus, engrafted wild-type
CPCs are capable of differentiating into mature, striated
cardiomyocytes in Speg / hearts. Speg immunostaining was
present in localized regions of all Speg / hearts injected with
wild-type CPCs (Fig. 9b, upper panels, three hearts from different
mice), however, the presence of striated, mature and well-
organized cardiomyocytes (by confocal imaging of cTnT
immunostaining) was evident throughout the myocardium of
these Speg / hearts, even outside of the regions of CPC
engraftment (Fig. 9b, lower panels). To further explore this
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labelled CPCs under echocardiographic guidance, at 13.5 dpc. The hearts were harvested on day 1 after birth (19.5 dpc) for histological analyses.
Immunoﬂuorescent staining was performed for sarcomeric (Sar) a-actin (red) and DAPI (blue). Merged confocal images show CPCs that have engrafted
and differentiated into cardiomyocytes (yellow). In both a,c, the scale bar, 200mm. LV, left ventricle; RV, right ventricle.
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concept, we repeated injections of wild-type CPCs into foetuses at
13.5 dpc, and on day 1 after birth the hearts were harvested,
enzymatically digested into single-cell suspensions and ﬂow
cytometry was performed to assess green ﬂuorescently labelled
cells (originating from the CPCs), and also for cells staining for
cTnT. Twelve representative ﬂow cytometry pseudo-colour
density plots of our analyses are shown in Fig. 9c (upper panels),
along with unstained cells as a negative control. The complete
gating strategy for these ﬂow cytometry experiments is shown in
Supplementary Fig. 6. Quantiﬁcation of the ﬂow cytometry data
revealed that on day 1 after birth, 6 days after the injection,
10.9±0.8% of the total cell population was ﬂuorescein isothio-
cyanate (FITC)-positive, ﬂuorescently labelled cells originating
from the injected CPCs (Fig. 9c, lower left panel). Moreover,
5.6±0.3% of the total cell population was FITC positive and also
stained positive for cTnT. These FITC-positive, cTnT-positive
cells represent CPCs that have differentiated into cardiomyocytes
in the day 1 hearts, although we cannot exclude a component of
cell fusion contributing to this population of cardiomyoctyes.
Additional assessment of entire hearts from CPC recipients
demonstrated no difference in CPC engraftment, or differentia-
tion of these cells into cardiomyocytes, between Speg genotypes
(Supplementary Fig. 7a). Further analyses revealed that in the
hearts, 14.2±0.9% of the cardiomyocytes were derived from
exogenous injected CPCs, while 85.8±0.9% were composed of
endogenous (FITC negative, cTnT positive) cardiomyocytes
(Fig. 9c, lower right panel). Also, these data were analogous
between Speg genotypes (Supplementary Fig. 7b). Supplementary
Table 1 provides the primary data regarding the ﬂow cytometry
analyses. Taken together, these data suggest that maturation of
the Speg / myocardium in mice receiving wild-type CPCs goes
beyond the concept of just CPC engraftment and replacement of
the abnormal myocardium, and that wild-type CPCs may have
paracrine actions that promote the maturation of endogenous
Speg / cardiomyocytes.
Beyond maturation, we also assessed the effect of injecting
CPCs expanded in culture on the number of endogenous
cardiomyocytes in recipient hearts, compared with cells from
hearts not injected with CPCs. As shown in Supplementary Fig. 8
(ﬂow cytometry pseudo-colour density plots of wild-type and
Speg mutant recipients in a; and composite data in b), hearts
receiving CPCs had a very similar percentage of cardiomyocytes
in their endogenous cell population (38.3±1.4%) compared
with hearts of mice not injected with CPCs (39.9±2.8%).
Furthermore, these percentages of cardiomyoctyes were very
similar between different Speg genotypes, in both groups
(Supplementary Fig. 8b, right panel). Supplementary Table 2
provides the primary data regarding these analyses.
Echocardiograms performed on day 1 after birth revealed that
Speg / mice (not receiving injections of vehicle or CPCs)
compared with Spegþ /þ mice had a signiﬁcant decrease in LV
ejection fraction (EF: 41±2.1% versus 63±1.5%) and fractional
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Figure 7 | Expression of Speg in mutant hearts after in utero injections of
CPCs. Confocal imaging of Speg immunostaining (green) in (a) Spegþ /þ
heart (left panel) and in Speg / heart (right panel) receiving no
CPCs (CPCs); and (b) representative images of Speg / hearts
receiving wild-type CPCs (þCPCsþ /þ , left panel) or mutant CPCs
(þCPCs / , right panel). In total, immunostaining for Speg was
performed on hearts of 13 Speg / pups (from 9 dams) receiving
wild-type CPCs, and 3 Speg / pups (from 6 dams) receiving mutant
CPCs. The sections in a,b were also counter stained with DAPI (blue),
and the scale bars, 20mm.
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Figure 8 | Maturation of cardiomyocytes in Speg / hearts after in
utero injections of CPCs. Confocal imaging of cardiac troponin T (cTnT,
red) in (a) Spegþ /þ heart (left panel) and Speg / heart (right panel)
receiving no CPCs (CPCs), and (b) representative images of Speg /
hearts receiving wild-type CPCs (þCPCs þ /þ , left panel) and Speg /
CPCs (þCPCs  / , right panel). Hearts for cTnT immunostaining
were performed on hearts of 13 Speg / pups (from 9 dams) receiving
wild-type CPCs, and 3 Speg / pups (from 6 dams) receiving mutant
CPCs, as described in Fig. 7b. The sections in a,b were also counter stained
with DAPI (blue), and the scale bars, 50mm.
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shortening (FS: 18±1.1% versus 31±1.1%), respectively
(Fig. 10a). Moreover, these Speg / mice had a signiﬁcant
decrease in the thickness of their septal and LV posterior walls,
and an increase in their LV internal diameters and volumes
(Fig. 10a). These changes were distinctly apparent during systole,
and not diastole (Supplementary Fig. 9), which is consistent with
an abnormality in contractile function. To determine whether
in utero administration of exogenous wild-type CPCs into Speg
mutant hearts would improve cardiac function, we injected CPCs
expanded in culture (or vehicle without cells) into hearts at 13.5
dpc, using micro-ultrasound guidance, and echocardiograms were
performed on day 1 after birth (19.5 dpc). The echocardiograms
revealed that Speg / mice receiving intra-cardiac injections at
13.5 dpc, but no CPCs, had no difference in LVEF and LVFS
compared with Speg / mice receiving no injections (Fig. 10a).
Thus, the injection itself at 13.5 dpc had no effect on cardiac
function postnatally. In Speg / mice receiving wild-type CPCs,
their LVEF and LVFS increased to 62±4% and 31±2%,
respectively, a level of function analogous to Spegþ /þ mice.
While septal and LV posterior walls were thinner in Speg /
mice, mutant mice receiving CPCs had wall thicknesses
comparable to Spegþ /þ mice. Also, the increased LV internal
diameter and volume seen in Speg / mice was alleviated by
treatment with CPCs, resulting in LV dimensions analogous to
wild-type mice (Fig. 10a). These data demonstrate that injection
of wild-type CPCs into Speg / mice in utero is able to rescue
these mice from heart failure in the postnatal period.
Our original report of Speg / mice on a 129SvC57BL/6
genetic background did not suggest developmental lethality10.
In the present study, we assessed live births from breeding of
Spegþ / mice on a pure C57BL/6 genetic background, injected
with either vehicle (phosphate buffered saline (PBS),  ) or wild-
type CPCs (þ ) expanded in culture. On a pure C57BL/6
background, the per cent of live Speg / births is only 5.4%,
instead of the expected Mendelian level of 25% with breeding of
Spegþ / mice (Fig. 10b). This suggests a signiﬁcant amount of
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Figure 9 | Wild-type CPCs engraft and promote maturation of Speg / hearts. (a) Confocal imaging of immunostaining for Speg (green, left panel),
cTnT (red, middle, panel) and merged image (yellow, right panel) in Speg / heart receiving wild-type CPCs (þCPCs þ /þ ) injections. The scale
bar, 10mm. (b) Representative confocal imaging of immunostaining for Speg (green, upper panels) in three individual Speg / hearts receiving wild-type
CPCs (þCPCs þ /þ ). In the lower panels, confocal imaging of immunostaining for cardiac troponin T (cTnT, red) in the same Speg / hearts receiving
wild-type CPCs (þCPCs þ /þ ). Overall, immunostaining for Speg was performed on hearts of 13 Speg / pups (from 9 dams) receiving wild-type
CPCs. The scale bar, 20mm. (c) Upper panels show 12 representative ﬂow cytometry pseudo-colour density plots (from a total of 20 neonatal hearts,
of 3 pregnant dams) from cells harvested from wild-type (þ /þ ) and Speg mutant ( / ) hearts at day 1, assessing green ﬂuorescently labelled cells
(FITC) and cells expressing cTnT (PE). Unstained cells (UC) serve as a negative control, and are shown in two ﬂow cytometry pseudo-colour density plots
on the left side of the upper panel. The left lower panel demonstrates the percentage of total cells that are green (white bar, n¼ 20), or green cells
expressing cTnT (black bar, n¼ 20). The right lower panel demonstrates percentage of cTnT-positive cardiomyocytes that are not green (endogenous,
white bar, n¼ 20) or green (exogenous, black bar, n¼ 20). Po0.0001; * versus endogenous cardiomyocytes using Student’s unpaired t-test.
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in utero death in Speg / mice on a pure C57BL/6 background.
Injection of wild-type CPCs at embryonic day 13.5 leads to live
births of 27.1% of Speg / pups. These data suggest that
injection of wild-type CPCs in utero signiﬁcantly increases the
live births of Speg / pups (ﬁvefold), and rescues the offspring
from in utero death. To determine whether the expression of Speg
in CPCs is important for the improved outcome, Speg mutant
CPCs were injected at embryonic day 13.5 and live births were
assessed. Compared with Speg / foetuses receiving wild-type
(þ /þ ) CPCs, injection of Speg mutant ( / ) CPCs resulted in
a signiﬁcant reduction in live births of Speg / pups (5.7%,
Supplementary Fig. 10), which is analogous to the level of live
births of Speg / pups receiving vehicle injections (Fig. 10b).
These data support the functional abnormalities of Speg /
CPCs. Finally, even in the absence of cardiac injections, Speg /
pups on a C57BL/6 background do not survive beyond postnatal
day 1.
Discussion
MLCK family members are known to play important roles in
myocyte function. MLCKs are responsible for myosin regulatory
light chain phosphorylation in skeletal and smooth muscle, and
this has recently been shown in heart muscle by cardiac MLCK29.
Phosphorylation of myosin regulatory light chains regulates
sarcomere assembly, and subsequent cardiac function29,30.
Knockdown of cardiac-MLCK in zebraﬁsh resulted in
immature-appearing sarcomere structures, and the suggestion
that cardiac-MLCK may be important for cardiogenesis30. We
have previously shown that the MLCK family member Speg is
upregulated during striated muscle differentiation8 and that mice
with a disruption in the Speg gene locus have a decrease in
phosphorylation of the sarcomeric protein a-tropomyosin, and
these mice develop a dilated cardiomyopathy10. Mutations in the
Speg gene have also been identiﬁed in humans with congenital
centronuclear myopathy, and these patients may also present
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with a dilated cardiomyopathy11. Further investigations in
Speg / mice showed a decreased number of cardiomyocytes
per mm3 of myocardium, suggesting an altered generation of cells
during development10, and immature-appearing cardiomyocytes
(Fig. 1). Thus, beyond a role for Speg in fully developed
cardiomyocytes, we proposed that Speg would also be critical for
the function of CPCs, and for the differentiation of CPCs into
mature, functional cardiomyocytes.
Our data demonstrate that CPCs harvested from Speg /
mice, compared with Spegþ /þ mice, have defects in all
*
*
– –+–
–
–
–
+
– – + +
Veh injection
CPCs injection
Veh injection
CPCs injection
Veh injection
CPCs injection
– –+–
–
–
–
+
– – + +
– –+–
–
–
–
+
– – + +
– –+–
–
–
–
+
– – + +
– –+–
–
–
–
+
– – + +
– –+–
–
–
–
+
– – + +
*
* *
*
* *
* *
*
*
‡†
LV
EF
 (%
)
80
60
40
20
0
LV
FS
 (%
)
50
40
30
20
10
0
‡†
‡†
NS
NS
IV
S,
s 
(m
m)
LV
PW
,s
 (m
m)
NS
‡†
NS
‡†
NS
LV
ID
,s
 (m
m)
LV
 v
ol
,s
 (m
m3
)
0.6
0.4
0.2
0.0
0.6
0.4
0.2
0.0
2.0
1.5
1.0
0.5
0.0
6
4
2
0
Pe
rc
en
t o
f l
ive
 b
irt
hs
30
20
25
15
10
5
0
*
†
NS
Veh injection
 CPCs injection
7
6
5
4
3
2
1
0
†
Fo
ld
 c
ha
ng
e 
sp
eg
–
/–
 
liv
e 
bi
rth
s
NS
+/+
−/−
+/+
−/−
++
+ +––
– – –
–
+
+
Figure 10 | Functional assessment of Speg / and Spegþ /þ hearts after in utero injections of CPCs. (a) Spegþ /þ (white bars, n¼ 6–7 per group)
and Speg / (black bars, n¼4–5 per group) mice received either no injection ( ), or intra-cardiac injection (þ ) with vehicle (Veh) or CPCs at 13.5 dpc.
On day 1 after birth (19.5 dpc), echocardiograms were performed to assess cardiac function. The left ventricles were assessed for ejection fraction (LVEF)
and fractional shortening (LVFS). Measurements for thickness of the intraventricular septum (IVS) and LV posterior wall (LVPW), and dimensions of the LV
internal diameter (LVID) and LV volume (LV vol) were performed during systole (s). Data are presented as mean±s.e.m. *Po0.05 versus Spegþ /þ mice
in the same group. zPo0.05 versus Speg / mice receiving no injection. wPo0.05 versus Speg / mice receiving Vehicle injection. NS, not signiﬁcant.
Analyses performed using one-way analysis of variance, followed by either Bonferroni’s or Newman–Keuls multiple comparison test. (b) Foetuses of
Spegþ / pregnant dams were injected with either Vehicle (Veh, n¼ 6 litters) or wild-type CPCs (n¼ 6 litters) at 13.5 dpc. On day 1 after birth (19.5 dpc),
the per cent of live births was assessed in Spegþ /þ (white bars) and Speg / (black bars) pups (left panel). P¼0.0012; * versus Spegþ /þ pups,
Vehicle injection; w versus Speg / pups, Vehicle injection. Analysis performed by Fisher’s exact test. In the right panel, fold change (mean±s.e.m.) in live
births of Speg / pups receiving either Vehicle or wild-type CPCs injection. P¼0.0198; w versus Speg / pups, Vehicle injection using Student’s
unpaired t-test.
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properties of progenitor cells. While the overall number of c-kit-
positive, lineage-negative cells is not decreased in Speg / hearts
(Fig. 3a), mutant CPCs show a marked defect in clone formation
(Fig. 3d), a decrease in clone size (Fig. 3b,c) and a reduction in
growth potential (Fig. 3e,f). Moreover, the inability of these cells
to express sarcomeric a-actin and cTnT under differentiation
conditions (Fig. 4), suggests that disruption of the Speg gene locus
in CPCs leads to a notable block in cardiomyocyte differentiation
and subsequent cellular maturation. As seen in Fig. 8, injection of
Speg mutant CPCs into a Speg / foetus does not result in
maturation of the recipient heart to the extent of a Speg /
foetus receiving wild-type CPCs. At this time, we are not certain
whether this functional defect in the Speg mutant CPCs is related
to an abnormality in their ability to engraft and survive, or an
alteration in the mutant cells to differentiate and interact with
surrounding cells or to produce paracrine actions. To our
knowledge, this is the ﬁrst evidence that disruption of a MLCK
family member leads to an abnormality in the functional
properties of CPCs. Moreover, these defects in CPCs, and altered
cardiomyocyte maturation, are associated with the development
of a dilated cardiomyopathy (ref. 10 and Figs 6 and 10).
Previously, we have shown that c-kit-positive CPCs, harvested
from mice at 16–18 dpc, are able to engraft, asymmetrically
divide, acquire a myocyte phenotype and regenerate adult
infarcted myocardium in mice20. In addition, other
investigators have shown that in cardiomyopathic hearts at the
time of transplantation, or congenital hearts at the time of
surgery, the number of c-kit-positive cells was threefold higher in
neonates compared with heart tissue from children 42 years of
age31. Furthermore, when isolating cardiosphere-derived cells
from human neonatal hearts, the cells had a larger population of
c-kit-positive cells (also Flk-1- and ISL1-positive cells) and a
greater regeneration potential when injected into adult rat hearts
after left anterior descending artery ligation, compared with
cardiosphere-derived cells from human adult hearts32. Taken
together, these studies demonstrated that CPCs can be isolated
from patients with cardiomyopathies or congenital heart
diseases31, and that CPCs harvested from foetal or neonatal
hearts (mouse and human, respectively)20,32 have tremendous
regenerative potential.
To further understand the importance of CPCs in the Speg
mutant phenotype, and to comprehend the therapeutic potential
of CPCs in utero, we investigated whether administering wild-
type CPCs into foetuses of Spegþ / breeding would curtail the
development of heart failure in the Speg mutant neonates. CPCs
injected into foetal hearts at 13.5 dpc showed evidence of
engraftment at 19.5 dpc, in the neonatal period after a normal
delivery. Confocal imaging revealed that wild-type CPCs were
able to differentiate and fully mature in the Speg / hearts
(Fig. 9a). In addition, these engrafted wild-type cells appeared to
also promote maturation of endogenous mutant cardiomyocytes
(Fig. 9b). To strengthen this concept, we repeated injections of
wild-type CPCs into foetuses at 13.5 dpc, and on day 1 after birth
the hearts were harvested and ﬂow cytometry was performed to
assess green ﬂuorescently labelled cells originating from the
CPCs, and also for cells staining for cTnT. Quantiﬁcation of the
ﬂow cytometry data revealed that on day 1 after birth, 10.9±0.8%
of the total cell population originated from the injected CPCs,
while 5.6±0.3% of the total cell population were engrafted cells
that had differentiated into cardiomyocytes. Further analyses
revealed that 14.2±0.9% of the hearts were composed of
cardiomyocytes derived from the exogenous injected CPCs, and
85.8±0.9% of the hearts were composed of endogenous
cardiomyocytes. While c-kit-positive cells have classically been
shown to directly engraft and regenerate cardiac tissue, it has also
been shown that c-kit-positive cardiac stem cells can interact with
endogenous cardiomyocytes through gap junctions to exchange
microRNAs (mi-499) and improve their differentiation and
integration potential33. Moreover, cardiospheres have been
shown to act through paracrine actions to promote
regeneration34. Our present data suggest that maturation of the
Speg / myocardium in mice receiving wild-type CPCs goes
beyond the concept of just CPC engraftment and replacement of
the abnormal myocardium. Future studies will focus on
mechanisms contributing to this novel maturation process,
including the importance of cell-to-cell interactions and
paracrine effects of the CPCs on endogenous cardiomyocytes.
To elucidate the potential of cell therapy promoting paracrine
effects in the present study, we considered comparing cardio-
myoctye maturation in mice receiving injections of CPCs in utero
with mice receiving cardiac injections of MSCs, which are known
to promote many of their actions by paracrine effects. However,
MSCs are signiﬁcantly larger than haematopoietic stem cells35,
which in tissue are comparable in size with c-kit-positive CPCs.
Moreover, it has been shown that a signiﬁcant decrease in
viability occurs when MSCs are passed through narrow-bore
needles (25–26 s gauge needle sizes)36. Thus, for technical
reasons, these experiments were not feasible, as the beveled
glass micropipettes used for the micro-ultrasound-guided
injection of CPCs in utero have a much smaller internal
diameter. While the small size of c-kit-positive CPCs allowed
for these cells to be injected, the larger MSCs lodged in the
beveled glass micropipettes and did not pass into the hearts when
injections were attempted.
Interestingly, assessment of the recipient hearts revealed that
overall engraftment of exogenously injected CPCs did not differ
between wild-type and Speg mutant hearts (Fig. 9c and
Supplementary Fig. 7). However, the CPCs that engrafted in
dysfunctional Speg mutant hearts promoted myocardial regen-
eration of both RV and LV walls (throughout the RV wall and
subendocardial regions of the LV and septum), and alleviated the
negative remodelling of the ventricular walls (Fig. 6). This was
further conﬁrmed by echocardiography, as administration of
CPCs in utero was able to improve LV function of Speg /
hearts, and normalize LV wall thickness and chamber dimensions
(Fig. 10). The appearance and function of Speg mutant hearts
after receiving CPCs was analogous to wild-type hearts on day 1
after birth. This improvement in cardiac function was also
associated with a signiﬁcant increase in live births of Speg /
mice after receiving wild-type CPCs. However, this increase in
live births of Speg / mice was totally lost when the foetuses
were injected with Speg mutant CPCs, demonstrating the
importance of Speg for CPC function in vivo (Supplementary
Fig. 10). While cellular therapy with mesangioblast progenitor
cells has been shown to prevent a dilated cardiomyopathy
in a model of Duchenne muscular dystrophy in mice37,
administration of cells was performed 5–6 weeks after birth. To
our knowledge, the present study provides the ﬁrst demonstration
that cardiac injection of CPCs in utero is able to mitigate heart
failure after birth.
We also observed that a subpopulation of cells engrafted, but
remained in an undifferentiated state, and formed a putative
niche (Fig. 5g–i). These ﬁndings allow us to speculate regarding
the therapeutic potential of CPCs when administered in utero.
The ability of the CPCs to engraft, differentiate and to promote
maturation of endogenous cardiomyocytes explains why CPCs
can provide more acute therapeutic beneﬁt. However, the
potential of CPCs engrafting and forming putative niches
provides a rationale for long-term therapy. Progenitor cell niches
offer an environment where CPCs remain in an undifferentiated
state, connected to supporting cells in the myocardium26.
Asymmetrical division of CPCs allows for these cells to
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generate daughter CPCs (permitting replenishment of the CPC
pool) and daughter committed cells that contribute to myocardial
regeneration under pathophysiologic conditions26,38,39. We
believe that the formation of putative niches by wild-type CPCs
in the myocardium of Speg mutant hearts may allow for a source
of normal CPCs in these dysfunctional hearts, which contain
abnormal endogenous CPCs. Further investigation into the
long-term beneﬁt of in utero CPC administration in Speg
mutant mice will help to elucidate the potential of CPC therapy
for long-term outcome in newborn diseases.
At the present time, foetal cardiac intervention (FCI) in
humans is a therapeutic tool that has been used to treat
conditions in which there is high risk for prenatal or neonatal
death, or diseases that will likely result in major cardiac
morbidity40. In these circumstances, the goal of FCI is to
improve survival or to improve cardiac growth, development
and function so as to alter a detrimental postnatal outcome.
FCI procedures are carried out using a percutaneous
ultrasound-guided approach in which a needle is used to gain
foetal access, and mechanical interventions are performed for
congenital cardiovascular anomalies40. With recent evidence that
CPCs41,42 and cardiosphere-derived cells43 have therapeutic
beneﬁt in human adult patients with ischaemic cardiomyopathy
or after myocardial infarction, respectively, we postulate that
in utero cell therapy may have future implications for the
treatment of foetal cardiovascular diseases with high risk for
postnatal morbidity and mortality.
Methods
Speg mutant mice. Speg / (mutant) mice were previously generated as
described10, and backcrossed nine consecutive generations to yield Speg / mice
on a pure C57BL/6 genetic background. Since the Speg / mice die shortly after
birth, all studies were performed on the offspring of Spegþ / (heterozygous)
breeding. Thus, Spegþ /þ (wild type) mice were littermates of Speg / mice.
Adipocyte differentiation. Mouse CPCs (Spegþ /þ and Speg / ) and mouse
MSCs (harvested from adipose tissue) were cultured until conﬂuent, and then
placed in adipose differentiation medium (Lonza). Every 3 days the medium was
changed between adipose differentiation medium and maintenance medium,
for a total of 14 days. On day 14, the cells were ﬁxed and stained with Oil Red O
(Sigma-Aldrich) as described1,2.
Isolation and characterization of mouse CPCs. For the cells used in the in utero
injections, hearts from three litters of day 1 newborn pups, each litter from a
different Spegþ / dam, were harvested as described below. The cells were kept
separate, and genotyping was performed to identify Spegþ /þ and Speg / CPCs.
Thus, for the in vivo studies, three independent harvests of CPCs were used. Cells
used for the in vitro studies were not only from these harvests, but also from the
hearts of additional day 1 newborn pups from litters of Spegþ / dams. To acquire
an adequate number of cells, the majority of studies were performed on CPCs
that were expanded in culture, and characterized prior to use. The experiments
performed on c-kit-positive lineage-negative cells that were not expanded in
culture are shown in Fig. 3a, as the ﬂow cytometry analyses were completed on
freshly isolated cells.
CPCs were quantitated from day 1 mouse hearts (Spegþ /þ or Speg / ) by
enzymatic dissociation in a solution containing collagenase I, 10mgml 1 and
collagenase II, 25mgml 1 (Worthington Biochemical). The cells (E1.5–2.5 106)
were incubated with anti-mouse c-kit antibody conjugated with PECy7
(eBioscience) and FITC anti-mouse Lineage Cocktail (BioLegend), and then sorted
by ﬂow cytometry for c-kit-positive, lineage-negative cells. For in vitro experiments,
cells harvested after enzymatic dissociation were cultured for 1–2 weeks in growth
medium containing DMEM/F12 medium (Lonza) supplemented with foetal bovine
serum (FBS, 10%, Invitrogen), murine basic ﬁbroblast growth factor (20 ngml 1,
PeproTech), murine epidermal growth factor (20 ngml 1, PeproTech), insulin/
transferrin/sodium selenite (Biowittaker) and leukaemia inhibitor factor (LIF,
10 ngml 1, Chemicon). The CPCs were then isolated with anti-mouse c-kit
(CD117) MicroBeads (Miltenyi Biotec), and lineage depletion performed by
incubating the cells with the Mouse Haematopoietic Progenitor Cell Enrichment
Kit (STEMCELL technologies) and collecting the negative fraction. Early passage
CPCs were characterized by FACS to demonstrate the presence of c-kit, and to
document their undifferentiated state. For antibodies see Supplementary Table 3.
To assess the differentiation potential of CPCs, cells were cultured in specialized
differentiation medium for 7 days and assayed by immunocytochemistry, ﬂow
cytometry and qRT-PCR (see sections below). For cardiomyocyte differentiation,
CPCs were cultured for 7 days in DMEM/F12 medium supplemented with reduced
FBS (2%), BMP 4 (50 ngml 1, PeproTech), TGF-b2 (10 ngml 1, PeproTech) and
an absence of LIF. For smooth muscle cell differentiation, CPCs were cultured for 7
days in Medium 231 with Smooth Muscle Differentiation Supplement (Invitrogen,
S0085) and FBS (5%), and for endothelial cell differentiation CPCs were cultured in
Clonetics Endothelial Cell Medium (Lonza, CC-3156). To differentiate cells in a
lineage unbiased manner, LIF was removed from the CPC growth medium and
dexamethasone (10 nM) was added.
Flow cytometry and immunocytochemistry. For characterization of CPCs, cells
were cultured in either growth medium or differentiation medium, washed with
PBS and detached using a non-enzymatic solution HyQTase (Thermo Fisher
Scientiﬁc). Cells suspensions were pre-incubated with rat IgG2b anti-mouse
CD16/CD32 monoclonal antibody (BD Bioscience) at room temperature for
15min prior to staining with speciﬁc antibodies or isotype matched control
antibodies. CPCs were incubated with the ﬁrst antibodies conjugated with
ﬂuorescence at 4 C for 30min, or incubated with the ﬁrst antibody followed by a
second antibody conjugated with ﬂuorescence at 4 C for 30min. If the target
protein was intracellular, the cells were ﬁxed and then permeabilized prior to
staining. To establish whether CPCs were lineage negative, cells were ﬁxed and
labelled for c-kit and haematopoietic markers. In addition, the expression of
proteins by immunocytochemistry and/or ﬂow cytometry for cardiomyocytes
(Nkx2.5, cTnT sarcomeric a-actin), smooth muscle cells (GATA6, calponin and
smooth muscle a-actin) and endothelial cells (Ets1, vWF, CD31 and Flk-1) was
determined. For antibodies, see Supplementary Table 3. Stained cells were washed
with PBS and analysed using a BD FACS Canto II. At least 10,000 events were
collected and data were analysed using FlowJo software.
Assessment of c-kit-positive, lineage-negative cells in heart tissue. Hearts
from Spegþ /þ and Speg / pups, 1 day after birth, underwent enzymatic
dissociation. Red blood cells were lysed, followed by counting of the remaining
cells. The cells were stained with anti-mouse c-kit antibody conjugated with PECy7
and FITC anti-mouse Lineage Cocktail, followed by ﬂow cytometric analysis.
C-kit-positive, lineage-negative cells were calculated as a percentage of the total
cells in the hearts.
Limiting dilution and clone formation. CPCs were plated at 100 cells per 100mm
diameter dish (low density, E1 cell per 60mm2) to obtain multicellular clones
derived from a single founder cell. At day 10, 20 and 40, clones were stained with
crystal violet. The dishes were photographed for colony counts. The clones with
450 cells were counted. To assay the number of cells per clone, we harvested
clones using cloning cylinders and counted the cell numbers with a Beckman cell
counter. Please note that we were unable to assess clonality by plating a single CPC
into wells of Terasaki plates because CPCs from Speg / hearts were unable to
survive sorting by FACS.
Growth analysis. For the studies assessing CPC growth, the same number of cells
harvested from Spegþ /þ or Speg / mice were plated, and cells were then
counted daily for 5 days or BrdU uptake into nuclei was assessed on day 5
(Roche, BrdU Labelling and Detection Kit).
qRT-PCR. Total RNA was isolated from mouse CPCs, either before or after muscle
differentiation, using Trizol reagent (Invitrogen), and reverse transcription was
performed using the SuperScript III First-Strand Synthesis System (Invitrogen).
QRT-PCR was performed using the Sybr green kit (Bio-Rad) in a StepOnePlus
Real-time PCR System (Invitrogen). Primers for mouse cTnT, MEF-2C, GATA6,
VEZF1 and GAPDH were purchased from Invitrogen. Expression of mouse cTnT,
MEF-2C, GATA6 and VEZF1 were normalized to GAPDH expression levels.
QRT-PCR was also performed for Speg and Nkx2.5 using TaqMan probes, and
normalized to GAPDH (Invitrogen). The RT-PCR reaction was performed using
TaqMan Fast Universal PCR Mix kit (Invitrogen) with 6-carboxyﬂuorescein
ﬂuorophore. A summary of the quantitative RT-PCR primers is provided in
Supplementary Table 4.
Transmission electron microscopy. Hearts from 18.5-dpc foetuses were ﬁxed
in 0.1M sodium cacodylate buffer containing 2% paraformaldehyde and 2.5%
glutaraldehyde for 2 h at room temperature and then overnight at 4 C. The
ventricular tissue was cut into thin strips and then subdivided into small cubes
constituting a randomized sampling of the thickness of the ventricular wall. The
foetuses were postﬁxed in 1% osmium tetroxide/1.5% potassium ferrocyanide,
dehydrated and embedded in Epon/Araldite resin as previously described10.
The blocks were then thin-sectioned for analysis by electron microscopy.
Quantitation of the ultrastructural composition of cardiomyocytes from
Spegþ /þ and Speg / hearts by transmission electron microscopy was performed
using a square array of 140 sampling points of intersecting lines as described44.
The number of points lying over speciﬁc structures (myoﬁbrils, mitochondria,
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nuclei or undifferentiated cytoplasm) was calculated as a percentage of the volume
composition of cardiomyocytes.
Immunohistochemistry. Hearts from mouse foetuses at 18.5 dpc or newborn
mouse pups at 19.5 dpc (day 1 after birth) were arrested in diastole by direct intra-
cardiac injections of cadmium chloride (0.1M). The hearts were then formalin
ﬁxed, dehydrated and embedded in parafﬁn. Sections (5 mm) were then stained for
analysis. Evaluation of heart tissue was performed by light and confocal microscopy
by targeted ﬂuorescent antibodies as described previously20,45. Fluorescent staining
was performed with antibodies targeting cTnT, sarcomeric a-actin, Speg and c-kit,
and also CPCs labelled with green ﬂuorescent dye PKH67 (Sigma-Aldrich) was
assessed by confocal imaging. For antibodies see Supplementary Table 3.
Quantitation of cardiomyocyte size. Sections (5mm) of hearts from Spegþ /þ
and Speg / mice at day 1 after birth (receiving either no injections or wild-type
CPCs at 13.5 dpc) were immunostained for cTnT (cardiomyocytes), DAPI (nuclei)
and Wheat Germ Agglutinin (cell border). Random images of cardiomyocytes from
the LV, RV and septum were captured using a ﬂuorescence microscope. We then
measured the shortest diameter across the nucleus of individual cells using ImageJ
by an investigator blinded to the groups, and the cross-sectional area of the cells
was calculated46,47 (300 cells per location, in each group).
Injections of CPCs in utero. Injections of CPCs were performed using the Vevo
2100 high-resolution micro-ultrasound system and a 50-MHz probe (VisualSonics,
and the Vevo Integrated Rail System II with Injection System). Timed pregnancies
of Spegþ / mice were performed to allow injections at 13.5 dpc. The genotypes of
the foetuses were not known at the time of the injections, thus all foetuses from a
speciﬁc pregnancy were injected with Spegþ /þ CPCs labelled with the green
ﬂuorescent dye PKH67, which incorporates into the membrane of cells and is
equally distributed to daughter cells when they divide, or Spegþ /þ CPCs harvested
from transgenic mice expressing enhanced GFP under the direction of the human
ubiqutin C promoter (C57BL/6-Tg(UBC-GFP)30Scha/J, Jackson Laboratories).
Foetuses were also injected with Speg / CPCs. For the injection procedure, the
dam was anaesthetized, a laparotomy performed, the uterine horn exposed in a
sterile manner and injections were performed directly through the uterus into the
walls of the LV, RV and septum using a beveled glass micropipette. Each location
was injected twice, with 2,500 cells in a volume of 70 nl PBS per injection. The
uterine horn was then placed back into the abdomen and a normal delivery of the
pups occurred 6 days later. Supplementary Table 5 provides an overview of the
number of pregnant dams studied, the number of foetuses injected and the number
of live births. The difference between the number of injected foetuses and the live
births are deaths that occurred in utero. The Harvard Medical Area Standing
Committee on Animals, Harvard Medical School, approved animal care and use for
all experiments in this study.
In a group of newborn pups that had received injections of green ﬂuorescently
labelled CPCs at 13.5 dpc, their hearts were harvested on day 1 after birth, and
enzymatically digested into single-cell suspensions. Flow cytometry was then
performed to assess the percentage of green ﬂuorescently labelled cells, and also for
cells staining for cTnT, from the total population of cardiac cells.
Echocardiography. A Vevo 2100 high-resolution micro-ultrasound system and a
50-MHz probe were used for transthoracic echocardiography on non-anaesthetized
newborn pups (day 1 after birth). The hearts were imaged in the two-dimensional
parasternal short-axis view, and an M-mode echocardiogram of the mid-ventricle
was recorded at the level of papillary muscles10,48. Wall thickness in systole
and diastole (LVPW,s; LVPW,d; IVS,s; and IVS,d), and the end-systolic and
end-diastolic internal dimensions of the LV (LVID,s; LVID,d) and the end-systolic
and end-diastolic volume of the LV (LV vol,s; LV vol,d) were measured from the
M-mode image.
(1) FS %¼ (LVID,d—LVID,s)/LVID,d 100;
(2) EF %¼ (LV vol, d—LV vol,s)/LV vol,d 100.
Echocardiograms were performed on all of the pups from a pregnancy, and
genotyping was performed later. Thus, the echocardiograms were performed in a
blinded manner, without prior knowledge of the genotype.
Statistical analysis. For comparisons between two groups, we used Student’s
two-tailed unpaired t-test, or Mann–Whitney U-testing for non-parametric
analyses where the data were not normally distributed. For the analysis of CPC
proliferation, the rate of growth was derived by ﬁtting the data to the exponential
growth curve, and then comparisons between groups were then made by Student’s
unpaired t-test. For comparisons of more than two groups, either a two-way
analysis of variance (ANOVA) or a one-way ANOVA (followed by Bonferroni’s or
Newman–Keuls post test) was used, depending on the number of comparisons
performed. For comparison of mortality between groups, Fisher’s exact test was
used. Statistical signiﬁcance for all comparisons was accepted at Po0.05. The
numbers of samples per group (n), or the numbers of experiments, are speciﬁed in
the ﬁgure legends.
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